History

2025

  • 07

    Designated as a Clinical Trial Sample Analysis
    Institution - Other Analyses
    (Nucleic Acid Analysis)

2024

  • 12

    Launched Medical Writing service

  • 11

    Selected for the national R&D project
    “Korean ARPA-H Project” (KHIDI)

  • 07

    Selected for the national R&D project
    “K-MELLODDY” (KHIDI)

  • 06

    Launched nucleic acids bioanalysis service (Preparation for nucleic acids bioanalysis designation)

2023

  • 06

    Appointment of CEO: In-Jin Jang

  • 03

    Established a joint venture [ABC Bioscience Inc.]

2022

  • 12

    Relocation of headquarters (Chungmuro)

2021

  • 03

    Launched statistical service

2020

  • 05

    Established APACE research institute

2019

  • 09

    GLP certified in the field of immunogenicity analysis from MFDS

  • 05

    GLP certified in the field of pharmacokinetic biomarkers analysis from MFDS

2018

  • 11

    Approval of venture company

  • 10

    Established APACE Inc. (Within Seoul National University Yeongeon Campus Appointment of CEO: Joo-Youn Cho)